Select Page

Press & Media

At GTP Bioways, we are open to media interest and inquiries regarding our business, services, and capabilities. You can use the resources on this page or reach out to our media relations team for specific inquiries. We are here to connect you with the right business leader or subject matter expert to provide the information you need.

Press Releases

Featured Articles

Press Kit


About GTP Bioways

GTP Bioways is a CDMO, offering a unique service in developing production processes and manufacturing biotherapies, antibody-drug conjugates and nanomedicines.
With its development and production sites based in France, GTP Bioways supports biopharma companies aiming to develop innovative molecules, from R&D through to clinical trials, thanks to its GMP production development and aseptic filling capabilities.
The majority of the Toulouse-based company’s shareholders are French. The various members of the GTP Bioways group will generate a turnover of €20 million in 2022. It employs 150 staff.

Press Contact

Mrs Laurence Padiolleau
Tel: +33 7 71 18 64 73

Please do not use this phone number or email to sollicit for services or products.

Latest press releases

GTP Bioways microbial bioproduction unit

GTP Bioways strengthens its bioproduction capacities with the opening of a new microbial production unit

Linkinvax completes first batch production of PanCov with GTP Bioways Biologics CDMO

LinKinVax completes first batch production of “PanCov”, its next generation multi-variant vaccine against covid and other coronaviruses, in collaboration with GTP Bioways


GTP Bioways is opening two new biopharmaceutical production units

Press kit

Press Kit – English version

Dossier de Presse – Version Française

Discover more about GTP Bioways services

GTP Bioways

Our facilities

GTP Bioways

Our approach

GTP Bioways

Our references